 LEXINGTON, Mass., May 25, 2022 GLOBE NEWSWIRE -- Agenus NASDAQ: AGEN, an immuno-oncology company with an extensive pipeline of therapeutics designed to activate the immune response to cancers and infections, today announced that its Annual Shareholders Meeting will begin at 3:30 p.m. ET on June 8, 2022 and will be conducted in a virtual format only. Registration for attendees will start at 3:15 p.m. ET. 